Log In
BCIQ
Print this Print this
 

Fluad

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionMF59-adjuvanted influenza vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationInfluenza virus
Indication DetailsTreat influenza virus infection; Vaccinate against influenza in children
Regulatory Designation U.S. - Accelerated Approval (Treat influenza virus infection)
PartnerPaxVax Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/29/2016

Undisclosed

Undisclosed

Undisclosed

08/25/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today